Ocugen Inc (OCGN)
1.005
+0.05
(+4.88%)
USD |
NASDAQ |
Nov 14, 16:00
1.03
+0.02
(+2.49%)
After-Hours: 17:07
Ocugen Revenue (Annual): 6.036M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.036M |
| December 31, 2022 | 2.488M |
| December 31, 2021 | |
| December 31, 2020 | 0.043M |
| December 31, 2019 | |
| December 31, 2018 |
| Date | Value |
|---|---|
| December 31, 2017 | |
| December 31, 2016 | |
| December 31, 2015 | |
| December 31, 2014 | |
| December 31, 2013 | 0.008M |
| December 31, 2012 | 0.026M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.043M
Minimum
2020
6.036M
Maximum
2023
2.856M
Average
2.488M
Median
2022
Revenue (Annual) Benchmarks
| Cytokinetics Inc | 7.53M |
| Scholar Rock Holding Corp | -- |
| Mirum Pharmaceuticals Inc | 186.37M |
| SpringWorks Therapeutics Inc | 5.447M |
| NeuroBo Pharmaceuticals Inc | -- |